Código QR

Potentiating Antibody-Dependent Cellular Cytotoxicity in Triple-Negative Breast Cancer via the Humanized Anti-CD147 Antibody

Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with high metastatic potential, poor prognosis, and the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). The lack of these receptors limits the standard treatments, su...

Descrición completa

Gardado en:
Principais autores: Kanyarat Thongheang, Thanathat Pamonsupornwichit, Kanokporn Sornsuwan, On-anong Juntit, Tawan Chokepaichitkool, Weeraya Thongkum, Umpa Yasamut, Chatchai Tayapiwatana
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2025-04-01
Series:Antibodies
Assuntos:
triple-negative breast cancer
CD147
antibody therapy
ADCC
humanized antibody
Acceso en liña:https://www.mdpi.com/2073-4468/14/2/36
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares